NEA Management Company, LLC - Q1 2014 holdings

$2.04 Billion is the total value of NEA Management Company, LLC's 28 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 24.1% .

 Value Shares↓ Weighting
GRPN  GROUPON INC$426,116,000
-33.4%
54,351,5820.0%20.92%
-32.3%
TSRO SellTESARO INC$290,503,000
+4.3%
9,854,255
-0.1%
14.26%
+6.0%
CVT SellCVENT INC$216,763,000
-18.4%
5,996,212
-17.9%
10.64%
-17.1%
CLVS  CLOVIS ONCOLOGY INC$157,920,000
+14.9%
2,279,7810.0%7.75%
+16.8%
EPZM  EPIZYME INC$146,777,000
+9.5%
6,446,0890.0%7.21%
+11.2%
GLYC NewGLYCOMIMETICS INC$140,032,0008,575,135
+100.0%
6.88%
SUPN  SUPERNUS PHARMACEUTICALS INC$95,211,000
+18.6%
10,650,0000.0%4.67%
+20.5%
HPTX  HYPERION THERAPEUTICS INC$74,413,000
+27.6%
2,884,2210.0%3.65%
+29.6%
FIO  FUSION-IO INC$74,044,000
+18.1%
7,038,3790.0%3.64%
+20.0%
MM  MILLENNIAL MEDIA INC$56,915,000
-4.8%
8,224,7520.0%2.79%
-3.3%
ITMN  INTERMUNE INC$44,883,000
+127.2%
1,341,0000.0%2.20%
+130.9%
SNSS  SUNESIS PHARMACEUTICALS INC$37,258,000
+39.5%
5,636,5730.0%1.83%
+41.7%
RNA NewPROSENSA HLDG N V$36,483,0006,480,171
+100.0%
1.79%
WIFI  BOINGO WIRELESS INC$30,293,000
+5.8%
4,467,9600.0%1.49%
+7.4%
TRVN NewTREVENA INC$29,960,0003,811,691
+100.0%
1.47%
NKTR  NEKTAR THERAPEUTICS$22,126,000
+6.8%
1,825,6000.0%1.09%
+8.5%
TRGT  TARGACEPT INC$21,692,000
+14.5%
4,566,6660.0%1.06%
+16.3%
ECOM SellCHANNELADVISOR CORP$21,010,000
-69.7%
556,692
-66.5%
1.03%
-69.2%
LXRX  LEXICON PHARMACEUTICALS INC$20,199,000
-3.9%
11,676,0000.0%0.99%
-2.3%
ZHNE  ZHONE TECHNOLOGIES INC$20,177,000
-21.0%
4,781,2900.0%0.99%
-19.7%
SellALIMERA SCIENCES INC$17,797,000
+41.2%
2,255,639
-15.9%
0.87%
+43.5%
RIGL  RIGEL PHARMACEUTICALS INC$12,583,000
+36.1%
3,243,1500.0%0.62%
+38.3%
OREX  OREXIGEN THERAPEUTICS INC$12,579,000
+15.4%
1,935,3000.0%0.62%
+17.5%
FOLD  AMICUS THERAPEUTICS INC$11,702,000
-11.9%
5,653,0290.0%0.57%
-10.6%
EXEL  EXELIXIS INC$7,813,000
-42.2%
2,207,0000.0%0.38%
-41.3%
TSPT  TRANSCEPT PHARMACEUTICALS INC$6,427,000
-8.3%
2,086,7550.0%0.32%
-6.8%
ARQL  ARQULE INC$5,167,000
-4.7%
2,520,3160.0%0.25%
-3.1%
NURO  NEUROMETRIX INC$134,000
-19.8%
57,2730.0%0.01%
-12.5%
WDAY ExitWORKDAY INCcl a$0-4,930
-100.0%
-0.02%
SLTM ExitSOLTA MED INC$0-2,859,577
-100.0%
-0.41%
CADX ExitCADENCE PHARMACEUTICALS INC$0-2,070,286
-100.0%
-0.90%
GLUU ExitGLU MOBILE INC$0-5,943,793
-100.0%
-1.11%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-05-01
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLYCOMIMETICS INC39Q3 20237.6%
AURINIA PHARMACEUTICALS INC37Q3 20235.0%
CHAMPIONS ONCOLOGY INC33Q3 20231.2%
LEXICON PHARMACEUTICALS INC32Q3 20232.0%
ADAPTIMMUNE THERAPEUTICS PLC31Q3 20239.3%
TREVENA INC31Q3 20213.3%
AKARI THERAPEUTICS PLC31Q2 20230.3%
ARDELYX INC29Q3 202111.9%
RIGEL PHARMACEUTICALS INC29Q2 20200.6%
EPIZYME INC28Q1 20209.6%

View NEA Management Company, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-12

View NEA Management Company, LLC's complete filings history.

Compare quarters

Export NEA Management Company, LLC's holdings